These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9609589)

  • 1. Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995.
    Pickar JH; Thorneycroft I; Whitehead M
    Am J Obstet Gynecol; 1998 May; 178(5):1087-99. PubMed ID: 9609589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "red queen" and endometrial hyperplasia.
    Gambrell RD
    Fertil Steril; 1994 Feb; 61(2):401-2. PubMed ID: 8299806
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ultrasonic evaluation of endometrial changes induced by cyclic sequential hormone substitution therapy].
    Berardesca C; Chiechi LM; Caradonna F; Loizzi V; Loizzi P
    Minerva Ginecol; 1998 Dec; 50(12):503-5. PubMed ID: 10069161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
    Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
    Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone and endometrial cancer.
    Gompel A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical aspects of hormone replacement therapy.
    Thorneycroft IH
    Prog Cardiovasc Dis; 1995; 38(3):243-54. PubMed ID: 7494885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are progestins really necessary as part of a combined HRT regimen?
    Sturdee DW
    Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: estrogen-progestin replacement therapy and endometrial cancer.
    McKnight B; Voigt LF; Beresford SA; Weiss NS
    J Natl Cancer Inst; 1998 Jan; 90(2):164-6. PubMed ID: 9450582
    [No Abstract]   [Full Text] [Related]  

  • 16. The endometrium--from estrogens alone to TSECs.
    Pickar JH
    Climacteric; 2009 Dec; 12(6):463-77. PubMed ID: 19905899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
    Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
    Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and the risk of endometrial cancer: A systematic review.
    Sjögren LL; Mørch LS; Løkkegaard E
    Maturitas; 2016 Sep; 91():25-35. PubMed ID: 27451318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits and risks of hormone replacement therapy: an epidemiologic overview.
    Harlap S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1986-92. PubMed ID: 1605289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.